Endothelial progenitor cells (CD34+ KDR+) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis;Endotelyal progenitor hücreler (CD34 + KDR +) ve monositler vasküler risk faktörleri ve yaygın ateroskleroza raǧmen iyi koroner kollateral gelişimini saǧlayabilirler

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 4, 2011, Pages 290-299

  Kocaman, Sinan Altan ^a   Yalçin, Mehmet Ridvan ^a   Yaǧci, Münci ^a   Şahinarslan, Asife ^a   Türkoǧlu, Sedat ^a   Arslan, Uǧur ^a   Kurşunluoǧlu, Nevruz ^a   Özdemir, Murat ^a   Timurkaynak, Timur ^a   Cemri, Mustafa ^a   Abaci, Adnan ^a   Boyaci, Bülent ^a   Çengel, Atiye ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Atherosclerosis; CD34; Collateral development; Endothelial progenitor cell; Logistic regression analysis; Monocyte; Vascular endothelial growth factor 2

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD34 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ORAL ANTIDIABETIC AGENT; VASCULOTROPIN RECEPTOR 2;

ADULT; ANGIOCARDIOGRAPHY; ANGIOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CELL MIGRATION; CELL SUBPOPULATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL COUNT; OBSERVATIONAL STUDY; PREDICTION; RISK REDUCTION; STEM CELL;

EID: 79958109738     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.078     Document Type: Article

References (30)

1. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardeñ G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000; 902: 230-9.
2. Ross R, Glomset J, Harker L. Response to injury and atherogenesis. Am J Pathol 1977; 86: 675-84.
3. Gulati R, Jevremovic D, Peterson TE, Witt TA, Kleppe LS, Mueske CS, et al. Autologous culture-modified mononuclear cells confer vascular protection after arterial injury. Circulation 2003; 108: 1520-6.
4. He T, Smith LA, Harrington S, Nath KA, Caplice NM, Katusic ZS. Transplantation of circulating endothelial progenitor cells restores endothelial function of denuded rabbit carotid arteries. Stroke 2004; 35: 2378-84.
5. Rauscher FM, Goldschmidt-Clermont PJ, Davis BH, Wang T, Gregg D, Ramaswami P, et al. Aging, progenitor cell exhaustion, and atherosclerosis. Circulation 2003; 108: 457-63.
6. Wassmann S, Werner N, Czech T, Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006; 99: e74-83.
7. Habib GB, Heibig J, Forman SA, Brown BG, Roberts R, Terrin ML, et al. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI investigators. Circulation 1991; 83: 739-46.
8. Hansen JF. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989; 117: 290-5.
9. Matsuo Y, Imanishi T, Hayashi Y, Tomobuchi Y, Kubo T, Hano T, et al. The effect of endothelial progenitor cells on the development of collateral formation in patients with coronary artery disease. Intern Med 2008; 47: 127-34.
10. Lambiase PD, Edwards RJ, Anthopoulos P, Rahman S, Meng YG, Bucknall CA, et al. Circulating humoral factors and endothelial progenitor cells in patients with differing coronary collateral support. Circulation 2004; 109: 2986-92.
11. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606.
12. Rentrop KP, Cohen M, Blanke H, Phillips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-92.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoproteins cholesterol in plasma without use of the ultracentrifuge. Clin Chem 1972; 18: 499-502.
14. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-7.
15. Kaminski A, Steinhoff G. Current status of intramyocardial bone marrow stem cell transplantation. Semin Thorac Cardiovasc Surg 2008; 20:119-25.
16. Kilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002; 13: 155-9.
17. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38: 1872-8.
18. Kornowski R. Collateral formation and clinical variables in obstructive coronary artery disease: the influence of hypercholesterolemia and diabetes mellitus. Coron Artery Dis 2003; 14: 61-4.
19. Kilian JG, Keech A, Adams MR, Celermajer DS. Coronary collateralization: determinants of adequate distal vessel filling after arterial occlusion. Coron Artery Dis 2002; 13: 155-9.
20. Abaci A, Oguzhan A, Kahraman S, Eryol NK, Ünal S, Arinç H, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999; 99: 2239-42.
21. Sherman JA, Hall A, Malenka DJ, De Muinck ED, Simons M. Humoral and cellular factors responsible for coronary collateral formation. Am J Cardiol 2006; 98: 1194-7.
22. Chittenden TW, Sherman JA, Xiong F, Hall AE, Lanahan AA, Taylor JM, et al. Transcriptional profiling in coronary artery disease: indications for novel markers of coronary collateralization. Circulation 2006; 114:1811-20.
23. Arras M, Ito WD, Scholz D, Winkler B, Schaper J, Schaper W. Monocyte activation in angiogenesis and collateral growth in the rabbit hind limb. J Clin Invest 1998; 101: 40-50.
24. Herold J, Pipp F, Fernandez B, Xing Z, Heil M, Tillmanns H, et al. Transplantation of monocytes: a novel strategy for in vivo augmentation of collateral vessel growth. Hum Gene Ther 2004; 15: 1-12.
25. Schaper J, Konig R, Franz D, Schaper W. The endothelial surface of growing coronary collateral arteries. Intimal margination and diapedesis of monocytes. A combined SEM and TEM study. Virchows Arch A Pathol Anat Histol 1976; 370: 193-205.
26. Heil M, Ziegelhoeffer T, Pipp F, Kostin S, Martin S, Clauss M, et al. Blood monocyte concentration is critical for the enhancement of collateral artery growth. Am J Physiol Heart Circ Physiol 2002; 283:H2411-9.
27. Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Çgel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis 2008; 197: 753-6.
28. Kocaman SA, Sahinarslan A, Akyel A, Timurkaynak T, Boyaci B, Çengel A. The association of circulating monocyte count with coronary collateral growth in patients with diabetes mellitus. Acta Diabetol 2010; 47: 49-54.
29. Shantsila E, Watson T, Lip GY. Endothelial progenitor cells in cardiovascular disorders. J Am Coll Cardiol 2007; 49: 741-52.
30. Kocaman SA, Sahinarslan A, Biberoglu G, Hasanoglu A, Akyel A, Timurkaynak T, et al. Asymmetric dimethylarginine and coronary collateral vessel development. Coron Artery Dis 2008; 19: 469-74.